相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient-a review of the literature
S. J. van Hal et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Efficacy of Usual and High Doses of Daptomycin in Combination with Rifampin versus Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
C. Garrigos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the Seesaw Effect)
Soo-Jin Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms
Soo-Jin Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis
M. Lefebvre et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
O. Murillo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Efficacy of Daptomycin in Implant-Associated Infection Due to Methicillin-Resistant Staphylococcus aureus: Importance of Combination with Rifampin
Anne-Kathrin John et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
Pamela A. Moise et al.
LANCET INFECTIOUS DISEASES (2009)
Infection Associated with Prosthetic Joints
Jose L. Del Pozo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2007)
Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis
MS Rouse et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Current concepts - Treatment of infections associated with surgical implants
RO Darouiche
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
Current concepts: Prosthetic-joint infections
W Zimmerli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus
P Vaudaux et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects
BH Dvorchik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection
A Saleh-Mghir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
分享论文
